Submission of Revised Audited Financial Results for the Quarter and Year Ended 31.03.2026 due to typographical error for Board Meeting held on 19.05.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gayatri BioOrganics Ltd has filed revised audited financial results for FY2026 to correct typographical errors in the originally submitted results. The company states there is no impact on financial performance, profitability, or cash flows. The company reported a net loss of Rs 111.18 lakh for FY2026, significantly higher than the loss of Rs 72.65 lakh in FY2025, with basic loss per share of Rs 0.14. Total expenses stood at Rs 111.18 lakh. The balance sheet reflects severe financial distress with negative Other Equity of Rs (11,579.31) lakh (vs Rs (3,700.49) lakh prior year) against paid-up capital of Rs 7,878.81 lakh. The auditors (MGR & Co) issued an unmodified opinion but included an Emphasis of Matter paragraph. The financial statements have been prepared on a going concern basis based on a comfort letter from promoters.
The company is in deep financial distress with mounting losses and negative equity far exceeding paid-up capital, raising serious concerns about its ability to continue operations. While the restatement corrects typographical errors, the underlying financial deterioration and going concern uncertainty are the real story for investors.